CureVac
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 |
|---|---|---|---|---|
Revenue | $14,509 | $12,373 | $22,567 | $16,483 |
Gross Profit | -31,224 | -29,316 | -31,030 | -7,798 |
EBITDA | -68,805 | -65,602 | -39,157 | |
EBIT | -74,688 | -70,731 | -45,438 | |
Net Income | -72,909 | -70,553 | -86,653 | -48,681 |
Net Change In Cash | 14,509 | 12,373 | 22,567 | 16,483 |
Free Cash Flow | -96,252 | -101,642 | -58,014 | -74,002 |
Cash | 202,634 | 300,152 | 402,452 | 464,145 |
Basic Shares | 224,313 | 224,291 | 223,988 | 223,914 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $52,656 | $67,420 | $102,990 | $48,900 |
Gross Profit | -91,079 | -116,573 | -135,205 | 34,727 |
EBITDA | -249,551 | -223,102 | -386,486 | -109,800 |
EBIT | -276,221 | -249,263 | -422,364 | -123,411 |
Net Income | -254,834 | -249,029 | -411,716 | -129,074 |
Net Change In Cash | 52,656 | 67,420 | 102,990 | 48,900 |
Free Cash Flow | -316,464 | -379,399 | -861,029 | 475,051 |
Cash | 402,783 | 495,797 | 811,464 | 1,322,593 |
Basic Shares | 220,833 | 189,074 | 186,012 | 132,195 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.34 |
2024-03-31 | -$0.39 |
2023-12-31 | -$0.42 |
2023-09-30 | -$0.22 |
